Gara Jalqabaatti › Saree Oljoo › Michigan › Ann Arbor
Qorannoo klinikaalii Saree Oljoo Ann Arbor, MI keessatti
Qorannoo 27 Saree Oljoo f Ann Arbor fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Michigan, Ann Arbor
A Study of PHST001 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Michigan Rogel Cancer Center, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · Miili 7 fagaatti
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
- fi 4 dabalataa
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Michigan, Ann Arbor
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Trial Site, Ann Arbor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Namoota walitti qabaa jiraSadarkaa 1
- University of Michigan, Ann Arbor
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
Namoota walitti qabaa jiraSadarkaa 3
- Trinity Health IHA - Obstetrics and Gynecology West Arbor, Ann Arbor
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Namoota walitti qabaa jiraQorannoo ilaalaa
- Trinity Health, Ann Arbor
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Namoota walitti qabaa jiraSadarkaa 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · Miili 7 fagaatti
- fi 6 dabalataa
E-Mindfulness Approaches for Living After Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
- University of Michigan Rogel Cancer Center, Ann Arbor
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Namoota walitti qabaa jiraSadarkaa 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
Namoota walitti qabaa jiraSadarkaa 1
- University of Michigan, Ann Arbor
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
Namoota walitti qabaa jiraSadarkaa 4
- University of Michigan Rogel Cancer Center, Ann Arbor
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
Namoota walitti qabaa jiraSadarkaa 2
- University of Michigan Comprehensive Cancer Center, Ann Arbor
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Namoota walitti qabaa jiraSadarkaa 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
- fi 5 dabalataa
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Trinity Health, Ypsilanti · Miili 7 fagaatti
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
Namoota walitti qabaa jira
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Namoota walitti qabaa jiraQorannoo ilaalaa
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Namoota walitti qabaa jira
- University of Michigan Comprehensive Cancer Center, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Ann Arbor
The Cancer of the Pancreas Screening-5 CAPS5)Study
Namoota walitti qabaa jiraSadarkaa 3
- University of Michigan, Ann Arbor
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Namoota walitti qabaa jiraSadarkaa 3
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Michigan, Ann Arbor
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Namoota walitti qabaa jiraSadarkaa 1
- University of Michigan, Ann Arbor
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Namoota walitti qabaa jiraQorannoo ilaalaa
- Trinity Health-Michigan, Ypsilanti · Miili 7 fagaatti
Qorannoo Saree Oljoo magaalota biroo keessatti
- New York City, NYQorannoo 136
- Houston, TXQorannoo 126
- Boston, MAQorannoo 112
- Nashville, TNQorannoo 81
- Los Angeles, CAQorannoo 73
- Edison, NJQorannoo 68
- St. Louis, MOQorannoo 64
- Queens, NYQorannoo 64
- Durham, NCQorannoo 64
- Chicago, ILQorannoo 59
- Philadelphia, PAQorannoo 56
- Dallas, TXQorannoo 55
Qorannoo biroo Ann Arbor keessatti
- Kansarii ProstateQorannoo 27
- Kansara Qara'a Non-Small CellQorannoo 26
- Saree (Gosoota Hunda)Qorannoo 25
- Dhibee QaraQorannoo 23
- Kansarii ColorectalQorannoo 23
- Cufama OnneeQorannoo 22
- Leukemia Myeloidii HamaaQorannoo 17
- Dhibee Onneessaa fi DhiigaQorannoo 16
- Kansarii PancreasQorannoo 14
- MelanomaQorannoo 12
- StrokeQorannoo 12
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 12
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.